As shown in Fig. S7, IGFBP7 mRNA levels were found to be upregulated in lymphoid neoplasm diffuse large B-cell lymphoma, esophageal carcinoma, glioblastoma multiforme, head and neck squamous cell carcinoma, acute myeloid leukemia, brain lower grade glioma, pancreatic adenocarcinoma, stomach adenocarcinoma, and thymoma. Here, IGFBP7 is linked to pancreatic adenocarcinoma.